GSK 257049
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 257049, covering 2013-01-18 to 2013-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region [Phase 2]